Skip to main content
Europe and Central Asia Europe and Central Asia
  • English
  • русский

Global Links

  • Visit UNICEF Global
  • High contrast
Europe and Central Asia Europe and Central Asia
    • EXPLORE UNICEF
      • About us
      • Our mandate
      • Regional Director
      • The situation for children
      • Where we work
      • Our voices: Young people from the region
      • Ambassadors and supporters
      • Partners
  • Press centre
Donate

Main navigation

  • What we do
  • Research and reports
  • Stories
  • Take action
Search area has closed.
Search area has opened.
SearchClose

Search UNICEF

  • Available in:
  • English
  • русский
  • Українська
22 results
  • Article (19)
  • Blog post (1)
  • News note (2)
  • Page (2)
  • (-) Press release (17)
  • Programme (2)
  • Report (10)
  • (-) Statement (5)
  • #ENDviolence (1)
  • Armed conflict (4)
  • Breastfeeding (1)
  • Child protection (1)
  • Childrens rights (2)
  • Climate change (1)
  • Climate change and impacts (1)
  • (-) COVAX (6)
  • COVID-19 (27)
  • Education (2)
  • Equity (1)
  • Executive Director (1)
  • Gender based violence (1)
  • Global polio eradication initiative (1)
  • Goodwill ambassadors (2)
  • (-) Health (13)
  • Health supplies (2)
  • (-) HIV/AIDS (0)
  • Humanitarian Action and Emergencies (4)
  • Humanitarian crisis and response (1)
  • Immunization (30)
  • Infant and young child nutrition (1)
  • Maternal health (2)
  • Migrant and refugee crisis (2)
  • Migration (1)
  • Migration and refugee crisis (1)
  • (-) Newborn health (4)
  • Nutrition (4)
  • Polio (4)
  • Poverty (1)
  • Refugee and migrant children (2)
  • Refugees (1)
  • Supply (2)
  • Teachers (2)
  • Vaccines (23)
  • ECA (3)
  • ECARO (2)
  • Europe and Central Asia (2)
  • Global (14)
  • Kyrgyzstan (1)
  • Republic of Moldova (1)
Press release
17 April 2020
Maintaining routine immunization services vital during the COVID-19 pandemic – WHO and UNICEF
https://www.unicef.org/eca/node/5936
GENEVA/COPENHAGEN, 20 April 2020 - The COVID-19 pandemic is a stark reminder that infectious diseases know no borders. All countries are vulnerable, regardless of income levels or the strength of their health care systems. Across the European Region, where tens of millions of people have been living in lockdown for weeks, and over 100,000 people have died, the speed and devastation of the novel coronavirus has completely upended lives. The urgent need for a COVID-19 vaccine underscores the pivotal role immunizations play in protecting lives and economies. As scientists around the world work to develop a vaccine against the novel coronavirus and health care capacities are stretched in responding to COVID-19, national routine immunization programmes are more critical than ever before. Governments across the Region must use every opportunity possible to protect people from the many diseases for which vaccines are already available. When routine vaccinations are missed, the risk of disease outbreaks increases. In 2018, approximately 527 000 children missed their first-dose of measles-containing vaccine in the WHO European Region. One year later in 2019, the measles virus exposed immunity gaps in Europe, infecting over 100 000 people, across all age-groups. Protecting children, adolescents and adults from vaccine-preventable diseases through vaccination is a must for the sustainability of health care systems. “We know that vulnerability to infectious diseases anywhere is a threat to public health everywhere,” said Ms. Afshan Khan, UNICEF Regional Director for Europe and Central Asia. “It is critical that routine immunization programmes continue during this crisis, while adequately protecting health workers and individuals receiving vaccinations. Reaching the most vulnerable children who have missed routine immunizations in the past should be prioritized.” If, during these unprecedented times, local COVID-19 response measures cause temporary interruptions of routine immunization services, countries should plan to resume immunization services as quickly as possible after the situation stabilizes. Countries should be prepared to vaccinate those at higher risk and ensure everyone, including the most marginalized, will have equal access to a COVID-19 vaccine when it becomes available. “ We can prevent further impact of COVID-19 on our healthcare systems by assuring that individuals of all ages remain vaccinated according to national schedules. I urge countries to maintain immunization service delivery and drive demand for vaccination, through the life-course even at this difficult time. Prioritizing immunization is one of my four flagship areas and central to WHO’s vision for health in the new European Programme of Work” said Dr Hans Henri P. Kluge, WHO Regional Director for Europe. WHO and UNICEF will continue to support governments’ efforts to strengthen their immunization programmes, including through strategic planning for equitable provision of immunization, strengthening vaccine-preventable disease surveillance and community engagement and education. As we step into a new future, vaccines will continue to serve as a foundation for health and wellbeing for all. It is through solidarity, joint action and tireless commitment to leaving no one behind that we can create a healthier future together.   #Vaccineswork Georgia immunization UNICEF/UN0326765/Georgia
Press release
28 April 2022
UNICEF and WHO warn of ‘perfect storm’ of conditions for measles outbreaks, affecting children
https://www.unicef.org/eca/press-releases/unicef-and-who-warn-perfect-storm-conditions-measles-outbreaks-affecting-children
NEW YORK/ GENEVA, 27 April 2022 – An increase in measles cases in January and February 2022 is a worrying sign of a heightened risk for the spread of vaccine-preventable diseases and could trigger larger outbreaks, particularly of measles affecting millions of children in 2022, warn WHO and UNICEF. Pandemic-related disruptions, increasing inequalities in access to vaccines, and the diversion of resources from routine immunization are leaving too many children without protection against measles and other vaccine-preventable diseases. The risk for large outbreaks has increased as communities relax social distancing practices and other preventive measures for COVID-19 implemented during the height of the pandemic. In addition, with millions of people being displaced due to conflicts and crises including in Ukraine, Ethiopia, Somalia and Afghanistan, disruptions in routine immunization and COVID-19 vaccination services, lack of clean water and sanitation, and overcrowding increase the risk of vaccine-preventable disease outbreaks. Almost 17,338 measles cases were reported worldwide in January and February 2022, compared to 9,665 during the first two months of 2021. As measles is very contagious, cases tend to show up quickly when vaccination levels decline. The agencies are concerned that outbreaks of measles could also forewarn outbreaks of other diseases that do not spread as rapidly. Apart from its direct effect on the body, which can be lethal, the measles virus also weakens the immune system and makes a child more vulnerable to other infectious diseases like pneumonia and diarrhoea, including for months after the measles infection itself among those who survive.  Most cases occur in settings that have faced social and economic hardships due to COVID-19, conflict, or other crises, and have chronically weak health system infrastructure and insecurity. “Measles is more than a dangerous and potentially deadly disease. It is also an early indication that there are gaps in our global immunization coverage, gaps vulnerable children cannot afford,” said Catherine Russell, UNICEF Executive Director. “It is encouraging that people in many communities are beginning to feel protected enough from COVID-19 to return to more social activities. But doing so in places where children are not receiving routine vaccination creates the perfect storm for the spread of a disease like measles.”   In 2020, 23 million children missed out on basic childhood vaccines through routine health services, the highest number since 2009 and 3.7 million more than in 2019. Top 5 countries with reported measles cases in the last 12 months, until April 2022 [1] Country Reported Measles cases Rate per million cases First dose measles coverage (%), 2019 [2] First dose measles coverage (%), 2020 [3] Somalia 9,068 554 46 46 Yemen 3,629 119 67 68 Afghanistan 3,628 91 64 66 Nigeria 12341 58 54 54 Ethiopia 3039 26 60 58 As of April 2022, the agencies report 21 large and disruptive measles outbreaks around the world in the last 12 months. Most of the measles cases were reported in Africa and the East Mediterranean region. The figures are likely higher as the pandemic has disrupted surveillance systems globally, with potential underreporting. Countries with the largest measles outbreaks since the past year include Somalia, Yemen, Nigeria, Afghanistan, and Ethiopia. Insufficient measles vaccine coverage is the major reason for outbreaks, wherever they occur. “The COVID-19 pandemic has interrupted immunization services, health systems have been overwhelmed, and we are now seeing a resurgence of deadly diseases including measles. For many other diseases, the impact of these disruptions to immunization services will be felt for decades to come,” said Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization. “Now is the moment to get essential immunization back on track and launch catch-up campaigns so that everybody can have access to these life-saving vaccines.” As of 1 April 2022, 57 vaccine-preventable disease campaigns in 43 countries that were scheduled to take place since the start of the pandemic are still postponed, impacting 203 million people, most of whom are children. Of these, 19 are measles campaigns, which put 73 million children at risk of measles due to missed vaccinations. In Ukraine, the measles catch-up campaign of 2019 was interrupted due to the COVID-19 pandemic and thereafter due to the war. Routine and catch-up campaigns are needed wherever access is possible to help make sure there are not repeated outbreaks as in 2017-2019, when there were over 115,000 cases of measles and 41 deaths in the country – this was the highest incidence in Europe. Coverage at or above 95 per cent with two doses of the safe and effective measles vaccine can protect children against measles. However, COVID-19 pandemic-related disruptions have delayed the introduction of the second dose of the measles vaccine in many countries. As countries work to respond to outbreaks of measles and other vaccine-preventable diseases, and recover lost ground, UNICEF and WHO, along with partners such as Gavi, the Vaccine Alliance, the partners of the Measles & Rubella Initiative (M&RI), Bill & Melinda Gates Foundation, and others are supporting efforts to strengthen immunization systems by: Restoring services and vaccination campaigns so countries can safely deliver routine immunization programmes to fill the gaps left by the backsliding; Helping health workers and community leaders communicate actively with caregivers to explain the importance of vaccinations; Rectifying gaps in immunization coverage, including identifying communities and people who have been missed during the pandemic; Ensuring that COVID-19 vaccine delivery is independently financed and well-integrated into overall planning for immunization services so that it is not carried out at the cost of childhood and other vaccination services; Implementing country plans to prevent and respond to outbreaks of vaccine-preventable diseases and strengthening immunization systems as part of COVID-19 recovery efforts. ###### Notes to Editors For more information on the 24-30 April WHO World Immunization Week campaign and all resources . [1] Source: Provisional data based on monthly data reported to WHO as of April 2022 [2] Source: WHO/UNICEF estimates of national immunization coverage, 2020 revision. [3] Source: WHO/UNICEF estimates of national immunization coverage, 2020 revision. Vaccination of children UNICEF Skopje, 17 January 2022: With a smile on her face, four-year-old Izabela is sitting in her mum’s lap waiting for MMR (measles, mumps, rubella) re-vaccination in “Gjorce Petrov” Polyclinic.
Statement
26 February 2020
Statement by UNICEF Executive Director Henrietta Fore on the disruption of immunization and basic health services due to the COVID-19 pandemic
https://www.unicef.org/eca/press-releases/statement-unicef-executive-director-henrietta-fore-disruption-immunization-and-basic
NEW YORK, 26 March 2020: “Around the world, the COVID-19 pandemic is overstretching health services as health workers are diverted to support the response. “Physical distancing is leading parents to make the difficult decision to defer routine immunization. “Medical goods are in short supply and supply chains are under historic strain due to transport disruptions. Flight cancellations and trade restrictions by countries have severely constrained access to essential medicines, including vaccines. “As the pandemic progresses, critical life-saving services, including immunization, will likely be disrupted, especially in Africa, Asia and the Middle East where they are sorely needed. “At the greatest risk are children from the poorest families in countries affected by conflicts and natural disasters. “We are particularly concerned about countries that are battling measles, cholera or polio outbreaks while responding to COVID-19 cases, such as Afghanistan, the Democratic Republic of Congo, Somalia, the Philippines, Syria and South Sudan. Not only would such outbreaks tax already stretched health services, they could also lead to additional loss of lives and suffering. At a time like this, these countries can ill-afford to face additional outbreaks of vaccine-preventable diseases. “The message is clear: We must not allow lifesaving health interventions to fall victim to our efforts to address COVID-19. “UNICEF is committed to supporting basic health care and immunization needs in the worst affected countries, and to doing so in a way that limits the risk of COVID-19 transmission. We are working hard to ensure adequate vaccine supplies are available in countries that need them. We are in close communication with global vaccine suppliers to ensure production is not disrupted and supply is managed in the best possible manner under these difficult circumstances. We are also providing greater support to governments to continue the supply of vaccines during this pandemic.   “In the days to come, governments may have to temporarily postpone preventive mass vaccination campaigns in many places to ensure that the delivery of immunization services does not contribute to COVID-19 spread, and to follow recommendations on physical distancing. “UNICEF strongly recommends that all governments begin rigorous planning now to intensify immunization activities once the COVID -19 pandemic is under control. These vaccination activities must focus on children who will miss vaccine doses during this period of interruption and prioritize the poorest and most vulnerable children. To successfully roll-out vaccines against COVID -19 when they become available, we need to ensure that our immunization programmes remain robust and can reach those that will need these vaccines the most.    “Immunization remains a life-saving health intervention. As the world's biggest buyer and supplier of vaccines, UNICEF will continue to play a pivotal role in supporting governments’ current and future immunization efforts.” Nurse Milka Babic performs immunization UNICEF/UNI218376/Pancic
Press release
25 April 2017
UNICEF reaches almost half of the world’s children with life-saving vaccines
https://www.unicef.org/eca/press-releases/half-children-life-saving-vaccines
  NEW YORK, 26 April 2017 – UNICEF procured 2.5 billion doses of vaccines to children in nearly 100 countries in 2016, reaching almost half of the world’s children under the age of five. The figures, released during World Immunization Week, make UNICEF the largest buyer of vaccines for children in the world.  Nigeria, Pakistan and Afghanistan, the three remaining polio-endemic countries, each received more doses of vaccines than any other country, with almost 450 million doses of vaccines procured to children in Nigeria, 395 million in Pakistan and over 150 million in Afghanistan. UNICEF is the lead procurement agency for the Global Polio Eradication Initiative. Access to immunization has led to a dramatic decrease in deaths of children under five from vaccine-preventable diseases, and has brought the world closer to eradicating polio. Between 2000 and 2015, under five deaths due to measles declined by 85 per cent and those due to neonatal tetanus by 83 per cent. A proportion of the 47 per cent reduction in pneumonia deaths and 57 per cent reduction in diarrhea deaths in this time is also attributed to vaccines. Yet an estimated 19.4 million children around the world still miss out on full vaccinations every year. Around two thirds of all unvaccinated children live in conflict-affected countries. Weak health systems, poverty and social inequities also mean that 1 in 5 children under five is still not reached with life-saving vaccines. “All children, no matter where they live or what their circumstances are, have the right to survive and thrive, safe from deadly diseases,” said Dr. Robin Nandy, Chief of Immunization at UNICEF. “Since 1990, immunization has been a major reason for the substantial drop in child mortality, but despite this progress, 1.5 million children still die from vaccine preventable diseases every year.” Inequalities persist between rich and poor children. In countries where 80 per cent of the world’s under-five child deaths occur, over half of the poorest children are not fully vaccinated. Globally, the poorest children are nearly twice as likely to die before the age of five as the richest. “In addition to children living in rural communities where access to services is limited, more and more children living in overcrowded cities and slum dwellings are also missing out on vital vaccinations,” said Nandy. “Overcrowding, poverty, poor hygiene and sanitation as well as inadequate nutrition and health care increase the risk of diseases such as pneumonia, diarrhea and measles in these communities; diseases that are easily preventable with vaccines.” By 2030, an estimated 1 in 4 people will live in urban poor communities, mainly in Africa and Asia, meaning the focus and investment of immunization services must be tailored to the specific needs of these communities and children, UNICEF said.     NOTES TO EDITORS: UNICEF works with World Health Organization (WHO), Gavi, the Vaccine Alliance, the Bill & Melinda Gates Foundation and others to ensure that vaccines protect all children – especially those who are the hardest to reach and the most vulnerable. World Immunization Week runs from 24 – 28 April 2017. For more information visit: www.unicef.org/immunization Immunisation session at Family Medicine Center #1 of Osh city, Kyrgyzstan UNICEF/UN041255/Pirozzi
Press release
23 February 2021
UNICEF begins shipping syringes for the global rollout of COVID-19 vaccines under COVAX
https://www.unicef.org/eca/press-releases/unicef-begins-shipping-syringes-global-rollout-covid-19-vaccines-under-covax
NEW YORK, 23 February 2021 – UNICEF has sent 100,000 syringes and 1,000 safety boxes for COVID-19 vaccinations to the Maldives by air freight from UNICEF’s humanitarian warehouse in Dubai—part of the first wave of COVID-19-related syringe shipments to begin rolling out in the coming days. Others in the first wave of shipments include Côte d'Ivoire and São Tomé and Príncipe. The 0.5 ml syringes and safety boxes are expected to arrive in Malé, Maldives on Tuesday. Over the next few weeks, UNICEF will ship more than 14.5 million 0.5 ml and 0.3 ml auto-disable syringes to more than 30 countries. While the 0.5 ml syringes are meant for use with the Serum Institute of India/AstraZeneca vaccine, the 0.3 ml ones are to be used with the Pfizer-BioNTech vaccine. “In this global fight against the COVID-19 pandemic, syringes are as vital as the vaccine itself,” said UNICEF Executive Director Henrietta Fore. “It is critical to have adequate supplies of syringes already in place in every country before the vaccine arrives so that the vaccine can be administered safely. This would allow immunization to start immediately and help turn the tide on this terrible virus.” The countries that will receive syringes in this initial tranche are from those included in the  COVAX indicative distribution  and that have put in requests to UNICEF to supply syringes. These shipments will support the country rollout of COVID-19 vaccines, and is part of work by the  COVAX Facility  to provide vaccines to all participating countries. The 0.5 ml syringes are being dispatched from UNICEF’s humanitarian warehouse in Dubai, while the 0.3 ml & 2 ml syringes will be transported directly from a manufacturer in Spain. The consignments will also include safety boxes for the safe disposal of syringes. Both syringes are of the auto-disable type, which means they cannot be used again after a single dose of vaccine has been administered. This reduces the risk of infection from blood-borne diseases as a result of syringe re-use. In all, UNICEF will be supplying up to 1 billion syringes and 10 million safety boxes to countries in 2021 to ensure they are ready for COVID-19 vaccinations. In order to meet the demand for these vital supplies,  UNICEF created a stockpile  of almost half a billion syringes in its warehouses in Copenhagen and Dubai in preparation for the broader rollout of COVID-19 vaccines in 82 low- and lower middle-income countries. UNICEF has been working with airlines, logistics operators and freight forwarders to ensure the syringes are treated as priority freight, whether they are being shipped direct from a manufacturer or from UNICEF warehouses to the destination country’s port of entry. Although the first deliveries will be transported by air, most of the syringes and safety boxes will be transported by sea due to the large amount of space they take up as cargo. UNICEF is aiming to make 2 billion COVID-19 doses available for delivery in 2021. Even before COVID-19, UNICEF was already the largest single vaccine buyer in the world, procuring over 2 billion vaccines annually in order to reach almost half of the world’s children under 5. In addition, the agency procures and supplies around 600-800 million syringes for regular immunization programmes annually. COVAX is a global collaboration co-led by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO, and includes UNICEF, which leads on procurement and delivery, as well as getting countries ready to receive vaccines. ##### Двое мужчин на складе с коробками UNICEF/UN0419486/Pableo
Press release
16 July 2018
Record number of infants vaccinated in 2017
https://www.unicef.org/eca/press-releases/record-number-infants-vaccinated-2017
  New York, 16 July 2018: A record 123 million infants were immunized globally in 2017, according to data released today by the World Health Organization and UNICEF.  The data shows that: 9 out of every 10 infants received at least one dose of diphtheria-tetanus-pertussis (DTP) vaccine in 2017, gaining protection against these deadly diseases.   An additional 4.6 million infants were vaccinated globally with three doses of the diphtheria-tetanus-pertussis vaccine in 2017 compared to 2010, due to global population growth. 167 countries included a second dose of measles vaccine as part of their routine vaccination schedule and 162 countries now use rubella vaccines. As a result, global coverage against rubella increased from 35 per cent in 2010 to 52 per cent.   The human papillomavirus (HPV) vaccine was introduced in 80 countries to help protect women against cervical cancer.  Newly available vaccines are being added as part of the life-saving vaccination package – such as those to protect against meningitis, malaria and even Ebola. Despite these successes, almost 20 million children did not receive the benefits of full immunization in 2017. Of these, almost 8 million (40 per cent) live in fragile or humanitarian settings, including countries affected by conflict. In addition, a growing share are from middle-income countries, where inequity and marginalization, particularly among the urban poor, prevent many from getting immunized.  As populations grow, more countries need to increase their investments in immunization programmes. To reach all children with much-needed vaccines, the world will need to vaccinate an estimated 20 million additional children every year with three doses of the diphtheria-tetanus-pertussis vaccine (DTP3); 45 million with a second dose of measles vaccine; and 76 million children with 3 doses of pneumococcal conjugate vaccine.  In support of these efforts, WHO and UNICEF are working to expand access to immunization by:  Strengthening the quality, availability and use of vaccine coverage data.  Better targeting resources. Planning actions at sub-national levels and Ensuring that vulnerable people can access vaccination services.    Notes to Editors Since 2000, WHO and UNICEF have jointly produced national immunization coverage estimates for each of the 194 WHO Member States on an annual basis. In addition to producing the immunization coverage estimates for 2017, the WHO and UNICEF estimation process revises the entire historical series of immunization data with the latest available information. The 2017 revision covers 37 years of coverage estimates, from 1980 to 2017.  Related links WHO/UNICEF 2017 country and regional immunization coverage data  Global Vaccine Action Plan 2012-2020   A baby girl receives her vaccination at a clinic in Serbia. UNICEF/UN040869/Bicanski A baby girl receives her vaccination at a clinic in Serbia.
Press release
13 April 2020
More than 117 million children at risk of missing out on measles vaccines, as COVID-19 surges
https://www.unicef.org/eca/press-releases/more-117-million-children-risk-missing-out-measles-vaccines-covid-19-surges
ATLANTA/GENEVA/NEW YORK, 14 April 2020: “As COVID-19 continues to spread globally, over 117 million children in 37 countries may miss out on receiving life-saving measles vaccine. Measles immunization campaigns in 24 countries have already been delayed; more will be postponed. “During this challenging period, the Measles & Rubella Initiative (M&RI) expresses solidarity with families, communities, governments and emergency responders and joins our global immunization and health partners, including those within Gavi, the Vaccine Alliance and the Global Polio Eradication Initiative (GPEI) in our collective focus and fight against the threat of COVID-19. The pandemic sweeping the globe requires a coordinated effort and commitment of resources to ensure frontline health workers around the world are protected, as they face and respond to this new threat. At the same time, we must also champion efforts to protect essential immunization services, now and for the future. “The World Health Organization (WHO) has issued new  guidelines  endorsed by the Strategic Advisory Group of Experts on Immunization -- to help countries to sustain immunization activities during the COVID-19 pandemic. The guidelines recommend that governments temporarily pause preventive immunization campaigns where there is no active outbreak of a vaccine-preventable disease. M&RI partners, which include the American Red Cross, the U.S. Centers for Disease Control and Prevention, UNICEF, the United Nations Foundation and WHO, strongly agree with these recommendations. We also urge countries to continue routine immunization services, while ensuring the safety of communities and health workers. The recommendations also ask governments to undertake a careful risk-benefit analysis when deciding whether to delay vaccination campaigns in response to outbreaks, with the possibility of postponement where risks of COVID-19 transmission are deemed unacceptably high. “If the difficult choice to pause vaccination is made due to the spread of COVID-19, we urge leaders to intensify efforts to track unvaccinated children, so that the most vulnerable populations can be provided with measles vaccines as soon as it becomes possible to do so. While we know there will be many demands on health systems and frontline workers during and beyond the threat of COVID-19, delivering all immunization services, including measles vaccines, is essential to saving lives that would otherwise be lost to vaccine-preventable diseases. “The M&RI supports the need to protect communities and health workers from COVID-19 through a pause of mass campaigns, where risks of the disease are high. However, this should not mean that children permanently miss out. Urgent efforts must be taken now at local, national, regional and global levels to prepare to close the immunity gaps that the measles virus will exploit, by ensuring that vaccines are available and that they reach children and vulnerable populations, as quickly as possible, to keep them safe. “Despite having a safe and effective vaccine for over 50 years, measles cases surged over recent years and claimed more than 140,000 lives in 2018, mostly of children and babies – all of which were preventable. Against this already dangerous backdrop, preventive and responsive measles vaccination campaigns have now been paused or postponed in 24 countries to help avert further spread of COVID-19. Campaigns expected to take place later in 2020 in an additional 13 countries may not be implemented. Together, more than 117 million children in 37 countries, many of whom live in regions with ongoing measles outbreaks, could be impacted by the suspension of scheduled immunization activities. This staggering number does not include the number of infants that may not be vaccinated because of the effect of COVID-19 on routine immunization services.  Children younger than 12 months of age are more likely to die from measles complications, and if the circulation of measles virus is not stopped, their risk of exposure to measles will increase daily.   “The M&RI salutes the heroism of health and emergency workers across the globe, and we recognize the vital role they play in delivering clear, trusted information, as well as preventive and supportive care within their communities. We must invest in health workers and ensure they are protected from infection and empowered as part of sustainable and functioning primary health systems. They are the first line of defense against global epidemics. We also recognize the role of parents and caregivers in ensuring their children are vaccinated by following physical distancing recommendations in line with national guidance. Finally, we call on countries and local leaders to implement effective communication strategies to engage communities, ensure supply and demand for vaccination remains strong, and help assure a healthy life for every child especially in this challenging time.” #####   Notes to Editor   About Measles & Rubella Initiative: The Measles & Rubella Initiative (M&RI) is a global partnership, founded by the American Red Cross, the U.S. Centers for Disease Control and Protection, UNICEF, the United Nations Foundation and WHO, that is committed to achieving and maintaining a world without measles, rubella and congenital rubella syndrome. Founded in 2001, the Initiative has helped vaccinate over 2.9 billion children and save over 21 million lives by increasing vaccination coverage, improving disease response, monitoring and evaluation, and building public confidence and demand for immunization. The Initiative works closely with Gavi, the Vaccine Alliance to achieve these goals. For more information, visit us at  www.measlesrubellainitiative.org  and follow  us on Twitter . More information on measles: WHO  factsheet ; CDC  measles  updates; Latest  WHO measles surveillance data For WHO guidelines for immunization during COVID-19,  click here For more information about COVID-19, visit  https://www.unicef.org/coronavirus/covid-19 For UNICEF’s work immunization, visit  https://www.unicef.org/immunization   Kyrylo UNICEF/UN0201071/Krepkih
Press release
18 December 2020
UNICEF outlining plans to transport up to 850 tonnes of COVID-19 vaccines per month on behalf of COVAX, in ‘mammoth and historic’ logistics
https://www.unicef.org/eca/press-releases/unicef-outlining-plans-transport-850-tonnes-covid-19-vaccines-month-behalf-covax
NEW YORK, 18 December 2020 – UNICEF could potentially transport up to 850 tonnes of COVID-19 vaccines per month in 2021, should such quantities become available, according to a new assessment. This is more than double the average weight of vaccines UNICEF transports every month. The assessment is part of  UNICEF’s work  to lead on the procurement and delivery of COVID-19 vaccines for 92 low- and lower middle-income countries on behalf of the  COVAX Facility , in collaboration with the Pan American Health Organization (PAHO). “This is a mammoth and historic undertaking,” said Henrietta Fore, UNICEF Executive Director. “The scale of the task is daunting, and the stakes have never been higher, but we are ready to take this on.” The UNICEF assessment looked at global airfreight capacity and transport routes to better understand the challenges of delivering COVID-19 vaccines in 2021. It found that commercial airlines will be able to deliver vaccines to almost all 92 low- and lower-middle-income countries, which are among the 190 economies participating in the COVAX Facility, at an estimated cost of up to US$70 million. Comparing vaccine volume estimates against commercial and cargo routes across the globe, the assessment also found that current air cargo capacity would be sufficient to make deliveries covering 20 per cent of the population for most of the 92 countries. COVID-19 vaccines are expected to be primarily shipped using existing passenger and cargo flight capacity, although charters or alternative transport options may still be needed for some small countries and others with access issues. UNICEF is working with airlines and the wider logistics industry to prioritise the delivery of COVID-19 vaccines around the world. One major challenge in the COVID-19 vaccine operation is local cold chain capacity for vaccine storage within some low- and lower-middle-income countries. UNICEF, WHO and Gavi, the Vaccine Alliance, developed a  guidance note on supply and logistics  to help countries develop their supply chain strategies to receive, store, distribute and manage COVID-19 vaccines and related products. Given the range of storage temperatures required for COVID-19 vaccines, countries will continue to train logisticians and health workers on how to keep COVID-19 vaccines at the right temperatures. As part of  a programme that started in 2017 , with support from Gavi, UNICEF continues to procure and support the installation of 70,000 cold-chain fridges in lower-income countries by the end of 2021, which will help in the roll-out of COVID-19 vaccines that need to be stored at 2 to 8 degrees Celsius. Almost half of these will be solar powered. UNICEF, WHO and Gavi are also working to help countries prepare and develop  national deployment and vaccination plans  for the large-scale roll out of COVID-19 vaccines. Currently, countries are continuing to  monitor their readiness  against key milestones, which include expediting regulatory approvals and putting in place ways to monitor vaccine safety. In addition, a UNICEF meeting this week with more than 300 vaccine procurement experts globally, including government officials, looked at ways to procure and roll-out COVID-19 vaccines and strengthen regulatory systems and supply chains. Funding is critical. UNICEF has called for US$410 million to help countries with the delivery of vaccines, therapeutics and diagnostic tools in 2021. Further, UNICEF estimates a funding gap of US$133 million to cover in-country vaccine logistics and the required cold chain equipment for the poorest 92 countries. “With the imminent arrival of globally approved COVID-19 vaccines, we can begin to see signs of hope. But hope will not be restored by the vaccine alone,” said Fore. “Countries need urgent technical and financial support to strengthen their capacities for cold and supply chains, to train health workers, and to work with communities in combatting misinformation and building trust in vaccines. Without urgent funding and support, many of the poorest countries still risk being left behind.” ###### About COVAX COVAX is the vaccines pillar of the  ACT-Accelerator . It is co-led by the Coalition for Epidemic Preparedness Innovation (CEPI), Gavi, the Vaccine Alliance, and the World Health Organization (WHO) – working in partnership with developed and developing country vaccine manufacturers, UNICEF, the World Bank, Civil Society Organisations and others. COVAX is the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are rapidly available worldwide to economies of all financial means.  Find out more about UNICEF’s work on the COVID-19 vaccines  here , or about UNICEF’s work on immunization  here . Download photos and broll here:  UNICEF shipment UNICEF/UNI319459/Rocio Ortega
Statement
10 February 2021
In the COVID-19 vaccine race, we either win together or lose together
https://www.unicef.org/eca/press-releases/covid-19-vaccine-race-we-either-win-together-or-lose-together
NEW YORK/GENEVA, 10 February 2021 – “Of the 128 million vaccine doses administered so far, more than three quarters of those vaccinations are in just 10 countries that account for 60 per cent of global GDP. “As of today, almost 130 countries, with 2.5 billion people, are yet to administer a single dose. “This self-defeating strategy will cost…
Statement
15 December 2020
Teachers should be prioritized for vaccination against COVID-19
https://www.unicef.org/eca/press-releases/teachers-should-be-prioritized-vaccination-against-covid-19
NEW YORK, 15 December 2020 – “The COVID-19 pandemic has wreaked havoc on children’s education around the globe. Vaccinating teachers is a critical step towards putting it back on track.  “At their peak in late April 2020, nationwide school closures disrupted the learning of almost 90 per cent of students worldwide. While that number has dropped…
Press release
05 March 2021
COVID-19 vaccines shipped by COVAX arrive to the Republic of Moldova
https://www.unicef.org/eca/press-releases/covid-19-vaccines-shipped-covax-arrive-republic-moldova
Chisinau, 4 March 2021 - Today Moldova received 14 400 doses of the anti-COVID-19 vaccine, shipped via the COVAX Facility, a partnership between CEPI, Gavi, UNICEF and WHO. Moldova is the first country in Europe to receive vaccines from the COVAX facility.  The arrival marked a historic step towards the goal to ensure equitable distribution of anti-COVID-19 vaccines globally, in what will be the largest vaccine procurement and supply operation in history. The delivery is part of a first wave of arrivals in Moldova that will continue in the coming days and weeks. "We are the first country in Europe to receive a free vaccine through the COVAX platform and we are grateful for that. The 14,400 doses of Covid-19 vaccine will help us continue to immunize medical staff and reduce the spread of the virus. We thank all the states and organizations that support financially this global platform - Germany and other EU Member States, the United States, the United Kingdom of Great Britain and Northern Ireland, Canada, the European Commission, Japan and others - for their solidarity in these difficult times for all. We also thank WHO and UNICEF for their efforts to distribute the vaccines fairly,” said Maia Sandu, the President of the Republic of Moldova. The COVAX Facility is expected to deliver 24,570 doses of BioNTech- Pfizer COVID-19 vaccine and up to 264,000 indicative doses of AstraZeneca / SKBio COVID-19 vaccine to the Republic of Moldova in 2021. Team Europe, bringing together EU and its Member States, is one of the lead contributors to COVAX with over €2.2 billion, including another €900 million recently pledged by Germany. “The European Union continues to support the Republic of Moldova in the fight against COVID-19 pandemic. An equitable and fair access to vaccines is a key element in ending the pandemic.  The European Union and its Member States, acting together as 'Team Europe' are proud to support COVAX in delivering vaccines to our partners and today we see the first vaccines via COVAX platform arriving in the country. This is an important support for continuing the vaccination and the EU has been and will continue to be a reliable partner in this process,” said Peter Michalko, Ambassador of the European Union to the Republic of Moldova. On February 18, 2021 the United States pledged the initial $2 billion - out of a total $4 billion planned - to Gavi, the Vaccine Alliance, to support the global vaccination effort for COVID-19. "Through USAID, the United States contribution of more than $2 billion dollars to the COVAX Vaccine Alliance supports the purchase and delivery of safe and effective vaccines for Moldova’s most vulnerable and at-risk populations, including frontline health care workers. These vaccines are critical to controlling the COVID-19 pandemic and delivering hope that better, happier days are within sight,” said Dereck J. Hogan, U.S. Ambassador to the Republic of Moldova. Since the beginning of the pandemic, UN Moldova offered immediate support to the country, providing assistance in three main areas: health system preparedness, technical support and capacity building, and information and communication on COVID-19.  WHO leads the support of the country’s preparedness to receive and administer vaccines. “Vaccines will be a critical new tool in the battle against COVID-19: It is encouraging to see so many vaccines in development. Working as quickly as they can, scientists from across the world are collaborating and innovating to bring us tests, treatments and vaccines that will collectively save lives and end this pandemic,” said Dr Igor Pokanevych, WHO Representative in the Republic of Moldova. ”However, vaccines alone will not end the pandemic. Ongoing public health measures to prevent transmission will still be needed alongside vaccination, including adhering to testing and quarantine measures, mask wearing, hand hygiene and physical distancing.” UNICEF is leveraging its experience as the largest single vaccine buyer in the world and working with manufacturers and partners on the procurement of anti-COVID-19 vaccine doses, as well as freight, logistics and storage. UNICEF already procures more than 2 billion doses of vaccines annually for routine immunization and outbreak response on behalf of nearly 100 countries.  “Vaccines are among the greatest advances of modern medicine. Sustainable supply of the vaccines is the only way out of this crisis, to ensure that vaccination is available for all,” said Maha Damaj, UNICEF Moldova Country Representative. “UNICEF looks forward to these vaccines being made available to the people most at risk, and to further ensuring that routine immunization services for other life-threatening infections are not disrupted.” Since the beginning of the pandemic, more than 180,000 Moldovans, including more than 10,000 children and more than 800 pregnant women, were infected with the virus and over 4,000 lives were lost because of Covid-19 infection.  The virus was confirmed to have reached the Republic of Moldova on 7 March 2020, when a Moldovan woman that returned from Italy was tested positive for the novel coronavirus.  Romania shipped the first donation of AstraZeneca’s COVID-19 vaccine to Moldova on 27 February, allowing Moldova to start vaccinating frontline medical workers on 2 March. Коробки с вакцинами UNICEF Moldova/ Vladimir Uvarov
Statement
04 December 2020
As the COVID-19 pandemic begins to enter a new phase, UNICEF reminds the world that ‘the light at the end of the tunnel needs to shine for all’
https://www.unicef.org/eca/press-releases/covid-19-pandemic-begins-enter-new-phase-unicef-reminds-world-light-end-tunnel-needs
NEW YORK, 4 December 2020 – “COVID-19 is the first truly global crisis we have seen in our lifetimes. No matter where we live, the pandemic affects every one of us. Children have been seriously impacted. However, with more news about promising vaccines, and as we begin to imagine a day when COVID-19 is behind us, our guiding principle must be that the light at the end of the tunnel needs to shine for all. “This is why UNICEF has enthusiastically joined the Advance Market Commitment of the COVAX Facility to allow low- and lower-middle income countries access to COVID-19 vaccines. It is the best way to make sure that, as vaccines become available, no country is pushed to the back of the line. This would not only be fundamentally unfair, it would be unwise. The whole world will remain vulnerable to the virus until countries with the weakest health systems are protected from it as well. “In order for the COVAX Facility to work and guarantee equitable and affordable access to low- and lower-middle income countries, we need a global commitment to support and capitalize it, but also to finance the delivery of vaccines and associated supplies such as syringes and safety boxes. Governments must work together to ensure that COVID-19 vaccines are affordable and accessible to all countries. High-income countries should invest financially in the Advance Market Commitment and in UNICEF’s COVID-19 vaccine delivery efforts. All countries should take a strong stand against export controls on – and unnecessary stockpiling of – commodities for the COVID-19 response.  “UNICEF is also leveraging our unique strengths in community engagement and vaccine supply to make sure that countries participating in the COVAX Facility have safe, fast and equitable access to the vaccine. This is an enormous undertaking and many challenges still lay ahead.  As the largest vaccine buyer in the world,  procuring more than 2 billion doses  annually for routine immunization and outbreak response on behalf of nearly 100 countries, UNICEF is c oordinating and supporting  the procurement,  international freight , and in-country distribution of COVID-19 vaccines for the COVAX Facility. “Together with WHO, PAHO, GAVI and other partners at the global and regional levels, UNICEF is also working to support countries to ‘ready’ their immunization programmes for this historic roll-out. This includes assessing capacity and helping countries to strengthen their cold and supply chains so that they have adequate infrastructure to transport and store the vaccines for delivery to the frontlines. “However, the existence of a safe and effective COVID-19 vaccine alone will not end the pandemic. We need a diverse set of tools to help slow the spread of COVID-19, including diagnostics and treatments, as well as a continuance of preventive measures such as hand washing, physical distancing and mask wearing. UNICEF is providing governments with access to personal protective equipment, validated testing approaches, and proven treatments. In addition, UNICEF continues to work with multilateral partners to support governments with infection prevention control, water, sanitation and hygiene supplies, physical distancing, surveillance, contact tracing, case identification and community referral systems to stem the pandemic. “Lastly, we continue to help countries ensure the continuity of key essential services for women, children and young people – especially the most vulnerable. COVID-19 related disruptions have had a heavy impact on children: on their safety, their well-being, their future. Even as the fight against the disease enters into a hopeful new phase, we must not forget the work ahead of us to respond, recover and reimagine a better world for children.” ### Download photos  and broll here . For more information about COVID-19, visit  www.unicef.org/coronavirus . Find out more about UNICEF’s work on the COVID-19 vaccines  here , or about UNICEF’s work on immunization  here . About the Reimagine Campaign  In response to the COVID-19 pandemic, UNICEF has launched Reimagine — an urgent appeal to governments, the public, donors and the private sector to support UNICEF’s efforts to respond, recover and reimagine a world currently besieged by COVID-19. Together, we can prevent this pandemic from becoming a lasting crisis for children—especially the most vulnerable—and Reimagine a fairer world for every child. Join us:  https://www.unicef.org/coronavirus/covid-19/donate
  • Prev
    • 1
      • 1
      • 2
  • Next

Footer

UNICEF Home
  • What we do
  • Situation for children
  • Where we work
Data, Research and Reports
  • Publications
  • Partners
  • Ambassadors and Supporters
Become a donor

Social

Footer Secondary

  • Contact us
  • Legal

Footer tertiary

  • Report fraud, abuse, wrongdoing